Development of this evidence summary

Development of this evidence summary

The evidence summary: process guide (2017) sets out the process NICE uses to select topics for evidence summaries and details how the summaries are developed, quality assured and approved for publication.

Expert advisers

Dr Christopher Kobylecki, Consultant Neurologist, Greater Manchester Neurosciences Centre, Salford Royal NHS Foundation Trust.

Dr Hilary Tyne, Consultant Neurologist, Salford Royal NHS Foundation Trust.

Declarations of interest

Dr Christopher Kobylecki: honoraria for delivering educational meetings (content developed independently) from Ipsen, UCB Pharma; travel support to attend international meetings from Britannia Pharmaceuticals; honoraria for teaching from Teva Pharmaceuticals.

Dr Hilary Tyne: honorarium from UCB pharma for giving an educational talk; received November 2016.

About this evidence summary

Evidence summaries provide a summary of the best available published evidence for selected new medicines, unlicensed medicines or off‑label use of licensed medicines.

The summaries assess the strengths and weaknesses of the best available evidence to inform health professionals and commissioners' decision-making.

This summary is not NICE guidance.

ISBN: 978-1-4731-2383-0